Minisyston 20 fem, 100 mcg+20 mcg 21 pcs

Minisistone has estrogen-gestagenic, contraceptive action.

Levonorgestrel in combination with ethinylestradiol blocks the release of releasing releasing factors (luteinizing and follicle stimulating) of the hypothalamus, inhibits the secretion of gonadotropic hormones by the pituitary gland, and thus inhibits ovulation; increases the viscosity of mucus in the cervix, which makes it difficult for sperm to enter the uterine cavity.

When taken regularly, it normalizes the menstrual cycle and helps to prevent a number of gynecological diseases, including those of tumor nature.

Indications

Contraception, functional disorders of the menstrual cycle, dysmenorrhea.

Pharmacological effect

Miniziston has an estrogen-gestagenic, contraceptive effect.

Levonorgestrel in combination with ethinyl estradiol blocks the release of releasing factors (luteinizing and follicle-stimulating) of the hypothalamus, inhibits the secretion of gonadotropic hormones by the pituitary gland, and thus inhibits ovulation; increases the viscosity of mucus in the cervix, which makes it difficult for sperm to enter the uterine cavity.

When taken regularly, it normalizes the menstrual cycle and helps prevent a number of gynecological diseases, incl. tumor nature.

Special instructions

Prescribed with caution to patients with varicose veins, phlebitis, multiple sclerosis, epilepsy, endometriosis, and liver diseases.

You should stop taking it and consult a doctor if you experience migraine-like headaches for the first time, acute visual disturbances, pregnancy, acute thrombosis, bile stagnation or jaundice, or a significant increase in blood pressure.

Active ingredient

Ethinyl estradiol, Levonorgestrel

Composition

1 tablet contains:

levonorgestrel 100 mcg and ethinyl estradiol 20 mcg

Pregnancy

Contraindicated during pregnancy.

Contraindications

Hypersensitivity,
pregnancy,
hormone-dependent tumors of the mammary glands or uterus,
severe dysfunction and liver tumors,
diabetes mellitus with vascular complications,
thromboembolic diseases (including a history),
thrombosis of arteries and veins,
arterial hypertension (severe form).

Side Effects

In rare cases, headache, depression, nausea, diarrhea, breast tenderness;

with long-term use, very rarely – chloasma, deterioration of tolerance to contact lenses.

Storage conditions

In a place protected from light, at a temperature not exceeding 25°C.

Shelf life

5 years.

Manufacturer

Bayer Weimar GmbH & Co. KG, Germany